Mega Doctor News
The AMA’s COVID-19 webinar series continues this week by bringing the physician community the latest fact-based insights on COVID-19 therapeutic drugs and other treatment options from the nation’s highest-ranking subject matter experts.
During the tenth episode in the webinar series, AMA Immediate Past President Susan R. Bailey, M.D. will host several infectious disease experts from the Food and Drug Administration (FDA) to provide physicians with the most up-to-date information on Paxlovid and Molnupiravir—two therapeutics used in treating COVID-19. They will also discuss alternative treatment options for high-risk outpatients with mild-moderate COVID-19.
What: AMA webinar series, episode 10: therapeutics and other treatment options
When: Tuesday, February 1, 2022, 1 p.m. Central | 2 p.m. Eastern
Who: Susan R. Bailey, M.D., AMA Immediate Past President
Stephanie Troy, M.D., FDA Senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs
Aimee Hodowanec, M.D., FDA Senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs
John Farley, M.D., M.P.H., FDA Director of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs
Registration: To watch the live webinar, register here
